Research News and Research

RSS

Performing moderate or vigorous physical activity may lower the risk of heart failure

A six-year analysis of more than 94,000 adults in the U.K. Biobank with no history of heart failure at enrollment has found that engaging in moderate or vigorous physical activity may lower the risk of developing heart failure, according to new research published today in the American Heart Association's flagship journal Circulation.

29 Aug 2022

COVID-19 vaccine hesitancy found to be strong among Republican voters and Black people

Vaccine hesitancy remains a public health challenge that cuts across the country as the COVID-19 pandemic drags on, but Republican voters and Black people are among the most hesitant to get the shot, according to a new Portland State University study.

29 Aug 2022

Access to paid sick leave associated with lower mortality among working age-adults in the U.S.

Access to paid sick leave is linked to a lower rate of mortality among US working age men and women, according to new research in the American Journal of Preventive Medicine, published by Elsevier.

29 Aug 2022

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

Inside a living cell, proteins and other molecules are often tightly packed together. These dense clusters can be difficult to image because the fluorescent labels used to make them visible can't wedge themselves in between the molecules.

29 Aug 2022

Older people experiencing homelessness more likely to die soon

A quarter of the participants in a long-term study of older people experiencing homelessness in Oakland died within a few years of being enrolled, UC San Francisco researchers found.

29 Aug 2022

Combination of anemia and weak muscles increases the risk of death in older people

A study by researchers at the Federal University of São Carlos in Brazil and University College London in the United Kingdom shows that a combination of anemia and weak muscles in older people heightens the risk of death in ten years by 64% for men and by 117% for women.

29 Aug 2022

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

In a new story, scientists explored human herpesvirus-6 (HHV-6) and Epstein–Barr virus (EBV) reactivation among acute coronavirus disease 2019 (COVID-19) patients.

29 Aug 2022

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

Researchers receive $1.2 million Keck Foundation grant to find molecules for targeting the 'undruggable proteome'

The W.M. Keck Foundation has awarded a $1.2 million grant to medicinal chemistry and computational biology researchers at the University of Kansas and the University of Chicago focused on addressing a long-unresolved problem in biomedical research - finding molecules able to target the "undruggable proteome."

29 Aug 2022

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

According to the Centers for Disease Control and Prevention, more than 2.8 million Americans contract antibiotic-resistant bacterial infections each year, and approximately 35,000 of those patients do not survive their infection.

29 Aug 2022

Cost concerns lead to delay in Nigeria’s HPV vaccination plan

Nigeria's latest target for introducing a life-saving vaccine against cervical cancer has been branded unrealistic by health specialists as cost concerns have yet to be addressed, leaving thousands of Nigerian women at risk.

29 Aug 2022

Potential cause of racial disparity affecting infants with congenital heart disease discovered

Race was already known to matter when it came to health outcomes for infants with congenital heart disease (CHD), the most common birth defect, affecting 1 in 100 live births.

29 Aug 2022

Artificial intelligence-based risk score improves personalized care for women with heart attacks

Heart attacks in women are more likely to be fatal than in men. The reasons are differences in age and in comorbidity burden which makes risk assessment in women a challenge.

29 Aug 2022

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Around ten percent of the population in high income regions like Europe and the United States has been diagnosed with one or multiple autoimmune disorders.

29 Aug 2022

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful transcatheter aortic valve replacement (TAVR) and discharged home.

29 Aug 2022

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

Researchers evaluated pregnancy-specific responses to SARS-CoV-2 infection.

29 Aug 2022

Contact risks for COVID-19 transmission to healthcare personnel

Researchers analyzed the contact risks for SARS-CoV-2 spread to medical professionals in an infection outbreak in a hospital ward.

29 Aug 2022

What are the clinical characteristics and complications of patients with a monkeypox infection?

Researchers described the clinical characteristics and complications of monkeypox virus infections.

29 Aug 2022

$Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction$

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

$SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction$

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empagliflozin reduce cardiovascular death or hospitalization for heart failure by 20% in heart failure patients with mildly reduced and preserved ejection fraction.

28 Aug 2022

Research News and Research

Performing moderate or vigorous physical activity may lower the risk of heart failure

COVID-19 vaccine hesitancy found to be strong among Republican voters and Black people

Access to paid sick leave associated with lower mortality among working age-adults in the U.S.

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

Older people experiencing homelessness more likely to die soon

Combination of anemia and weak muscles increases the risk of death in older people

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Researchers receive $1.2 million Keck Foundation grant to find molecules for targeting the 'undruggable proteome'

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

Cost concerns lead to delay in Nigeria’s HPV vaccination plan

Potential cause of racial disparity affecting infants with congenital heart disease discovered

Artificial intelligence-based risk score improves personalized care for women with heart attacks

People with autoimmune disorder have a higher risk of developing cardiovascular disease

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

Contact risks for COVID-19 transmission to healthcare personnel

What are the clinical characteristics and complications of patients with a monkeypox infection?

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence